| TTM
|
11/30/2025
|
11/30/2024
|
11/30/2023
|
11/30/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
25,970,000 | 23,769,000 | 21,505,000 | 19,409,000 | 17,606,000 |
| Cost of Revenue
|
-2,791,000 | -2,551,000 | -2,358,000 | -2,354,000 | -2,165,000 |
|
Gross Profit
|
23,179,000 | 21,218,000 | 19,147,000 | 17,055,000 | 15,441,000 |
| Selling, General and Administrative Expenses
|
-9,065,000 | -8,061,000 | -7,293,000 | -6,764,000 | -6,187,000 |
|
Research and Development Expenses
|
-4,694,000 | -4,294,000 | -3,944,000 | -3,473,000 | -2,987,000 |
| Depreciation, Amortization and Depletion
|
-149,000 | -157,000 | -169,000 | -168,000 | -169,000 |
|
Operating Income/Expenses
|
-13,908,000 | -12,512,000 | -11,406,000 | -10,405,000 | -9,343,000 |
|
Total Operating Profit/Loss
|
9,271,000 | 8,706,000 | 7,741,000 | 6,650,000 | 6,098,000 |
| Total Net Finance Income/Expense
|
4,000 | 1,000 | 172,000 | 156,000 | -51,000 |
| Net Investment Income
|
40,000 | 27,000 | 18,000 | -8,000 | -40,000 |
| Irregular Income/Expenses
|
0 | 0 | -1,000,000 | 0 | 0 |
|
Other Income/Expense, Non-Operating
|
-34,000 | 0 | 0 | 1,000 | 1,000 |
|
Non-Operating Income/Expenses, Total
|
10,000 | 28,000 | -810,000 | 149,000 | -90,000 |
|
Pretax Income
|
9,281,000 | 8,734,000 | 6,931,000 | 6,799,000 | 6,008,000 |
|
Provision for Income Tax
|
-1,997,000 | -1,604,000 | -1,371,000 | -1,371,000 | -1,252,000 |
|
Net Income from Continuing Operations
|
7,284,000 | 7,130,000 | 5,560,000 | 5,428,000 | 4,756,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
7,284,000 | 7,130,000 | 5,560,000 | 5,428,000 | 4,756,000 |
|
Net Income after Non-Controlling/Minority Interests
|
7,284,000 | 7,130,000 | 5,560,000 | 5,428,000 | 4,756,000 |
|
Net Income Available to Common Stockholders
|
7,284,000 | 7,130,000 | 5,560,000 | 5,428,000 | 4,756,000 |
|
Diluted Net Income Available to Common Stockholders
|
7,284,000 | 7,130,000 | 5,560,000 | 5,428,000 | 4,756,000 |
| Basic EPS
|
17.93 | 16.73 | 12.43 | 11.87 | 10.13 |
| Diluted EPS
|
17.92 | 16.70 | 12.36 | 11.82 | 10.10 |
|
Basic Weighted Average Shares Outstanding
|
406,500 | 426,000 | 447,000 | 457,000 | 469,500 |
|
Diluted Weighted Average Shares Outstanding
|
406,750 | 427,000 | 450,000 | 459,000 | 470,900 |
|
Reported Normalized Diluted EPS
|
21.93 | 20.94 | 18.42 | 16.07 | 13.71 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
9,277,000 | 8,733,000 | 6,759,000 | 6,643,000 | 6,059,000 |
|
EBITDA
|
10,043,000 | 9,279,000 | 7,334,000 | 7,253,000 | 6,653,000 |
|
Normalized EBITDA
|
12,114,000 | 11,179,000 | 10,198,000 | 8,962,000 | 8,195,000 |
|
Normalized Income
|
8,909,380.86 | 8,941,000 | 8,281,000 | 7,377,000 | 6,457,000 |
11/30/2022 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade